HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is …
Over the last 12 months, insiders at HeartBeam, Inc. have bought $0 and sold $28,045 worth of HeartBeam, Inc. stock.
On average, over the past 5 years, insiders at HeartBeam, Inc. have bought $100,706 and sold $119,009 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $16,846 was made by BROUNSTEIN RICHARD D (Chief Financial Officer) on 2021‑12‑21.
2024-09-06 | Sale | director | 1,674 0.0048% | $2.34 | $3,917 | +1.73% | ||
2024-08-30 | Sale | director | 5,500 0.0156% | $2.31 | $12,705 | -0.85% | ||
2024-08-27 | Sale | director | 2,194 0.0061% | $2.26 | $4,958 | +3.33% | ||
2024-08-26 | Sale | director | 300 0.0009% | $2.38 | $714 | +2.20% | ||
2024-08-23 | Sale | director | 2,500 0.007% | $2.30 | $5,750 | -1.28% | ||
2023-09-29 | Sale | director | 5,500 0.0139% | $2.06 | $11,330 | -3.26% | ||
2023-09-28 | Sale | director | 8,000 0.02% | $2.04 | $16,320 | +2.45% | ||
2023-09-27 | Sale | director | 1,834 0.0047% | $2.11 | $3,870 | -0.48% | ||
2023-09-26 | Sale | director | 5,000 0.0128% | $2.09 | $10,450 | -1.89% | ||
2023-09-22 | Sale | director | 2,393 0.0065% | $2.21 | $5,289 | -3.70% | ||
2023-09-21 | Sale | director | 100 0.0003% | $2.41 | $241 | -7.93% | ||
2023-09-20 | Sale | director | 883 0.0027% | $2.46 | $2,172 | -11.81% | ||
2023-09-18 | Sale | director | 5,000 0.0151% | $2.46 | $12,300 | -16.73% | ||
2023-09-15 | Sale | director | 4,269 0.0127% | $2.43 | $10,374 | -15.04% | ||
2023-09-14 | Sale | director | 5,000 0.0133% | $2.17 | $10,850 | -15.04% | ||
2023-09-13 | Sale | director | 5,000 0.0118% | $1.93 | $9,656 | +7.73% | ||
2021-12-21 | Chief Financial Officer | 5,000 0.0206% | $3.37 | $16,846 | -51.25% | |||
2021-11-11 | CHIEF FINANCIAL OFFICER | 5,000 0.0367% | $5.99 | $29,950 | -62.58% | |||
2021-11-11 | director | 9,000 0.0661% | $5.99 | $53,910 | -62.58% | |||
2019-12-31 | Sale | SVP & General Counsel | 5,065 0.2894% | $46.62 | $236,130 | -3.20% |
Capper Joseph H | President & CEO | 178355 0.6689% | $2.39 | 12 | 20 | +16.88% |
GORMAN KIRK E | director | 173315 0.65% | $2.39 | 4 | 6 | <0.0001% |
PRYSTOWSKY ERIC N | director | 125706 0.4714% | $2.39 | 1 | 5 | <0.0001% |
BROUNSTEIN RICHARD D | Chief Financial Officer | 102075 0.3828% | $2.39 | 2 | 0 | <0.0001% |
THURMAN RANDY H | Chairman, President & CEO | 62536 0.2345% | $2.39 | 1 | 0 | <0.0001% |